Guided Therapeutics Inc (GTHP)
OTHER OTC:GTHP
US Market
Holding GTHP?
Track your performance easily

Guided Therapeutics (GTHP) Financial Statements

21 Followers

Guided Therapeutics Financial Overview

Guided Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.062; its P/E ratio is -1.93; Guided Therapeutics is scheduled to report earnings on November 13, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 6.00K$ 32.00K$ 44.00K$ 22.00K-
Gross Profit$ 4.00K$ 16.00K$ 11.00K$ 13.00K$ -79.00K
EBIT$ -355.00K$ -314.00K$ -1.49M$ -803.00K$ -1.99M
EBITDA$ -300.00K$ -259.00K$ -1.43M$ -751.00K$ -123.00K
Net Income Common Stockholders$ -441.00K$ -469.00K$ -1.60M$ -969.00K$ -9.61M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 1.36M$ 1.84M$ 2.31M
Total Assets$ 1.49M$ 1.67M$ 2.35M$ 2.89M$ 3.37M
Total Debt$ 2.02M$ 2.06M$ 2.09M$ 2.11M$ 2.18M
Net Debt$ 2.02M$ 2.06M$ 732.00K$ 274.00K$ -133.00K
Total Liabilities$ 5.51M$ 5.47M$ 5.66M$ 5.75M$ 6.25M
Stockholders Equity$ -4.01M$ -6.72M$ -3.31M$ -2.85M$ -2.88M
Cash Flow-
Free Cash Flow$ -100.00K$ -336.00K$ -438.00K$ -499.00K$ -341.00K
Operating Cash Flow$ -100.00K$ -336.00K$ -438.00K$ -499.00K$ -338.00K
Investing Cash Flow----$ -3.00K
Financing Cash Flow$ -46.00K$ 196.00K$ -41.00K$ 23.00K$ -42.00K
Currency in USD

Guided Therapeutics Earnings and Revenue History

Guided Therapeutics Debt to Assets

Guided Therapeutics Cash Flow

Guided Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis